Johan Wedell-Wedellsborg - 15 May 2023 Form 4 Insider Report for Y-mAbs Therapeutics, Inc. (YMAB)

Role
Director
Signature
/s/ Johan Wedell-Wedellsborg
Issuer symbol
YMAB
Transactions as of
15 May 2023
Net transactions value
+$981,404
Form type
4
Filing time
17 May 2023, 17:07:47 UTC
Previous filing
19 Jul 2022
Next filing
09 Jun 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction YMAB Common Stock Purchase $981,404 +101,740 +2.4% $9.65 4,280,205 15 May 2023 By WG Biotech ApS F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $9.64 to $10.00. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 Reporting Person is the majority owner of WG Biotech ApS and as such has sole voting and dispositive power with respect to such shares.